Effects of amino acid substitution polymorphisms of two DNA methyltransferases on susceptibility to sporadic colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 6, 2009, Pages 1183-1188

  Khatami, Fatemeh ^a   Noorinayer, Babak ^a   Mohebi, Seyed Reza ^a   Ghiasi, Somayeh ^a   Hashemi, Mohhamad ^b   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amino acid substitution polymorphisms; Colorectal cancer; DNMT1; Iran; MGMT

Indexed keywords

DMAP1 PROTEIN, HUMAN; DNA METHYLTRANSFERASE; MGMT PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; COLORECTAL TUMOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 77956637256     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Aquilina G, Biondo R, Dogliotti E, Meuth M, Bignami M. (1992). Expression of the endogenous O6-methylguanine-DNAmethyltransferase protects Chinese hamster ovary cells from spontaneous G:C to A:T transitions. Cancer Res, 2, 6471-5.
2. Chueh LL, Nakamura T, Nakatsu Y, et al. (1992). Specific amino acid sequences required for O6-methylguanine-DNA methyltransferase activity: analyses of three residues at or near the methyl acceptor site. Carcinogenesis, 13, 837-43.
3. Cohet C, Borel S, Nyberg F, et al. (2004). Exon 5 polymorphisms in the O6-alkylguanine DNA alkyltransferase gene and lung cancer risk in non-smokers exposed to second-hand smoke. Cancer Epidemiol Biomarkers Prev, 13, 320-3.
4. Deng CJ, Xie DW, Zhao YJ, Wang LD, Hong, JY. (1999). Identification of a novel genetic polymorphism of human O6-alkylguanine DNA alkyltransferase. Pharmacogenetics, 9, 81-7.
5. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK. (2001). Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res, 61, 3410-8.
6. Egyhazi S, Ma S, Smoczynski K, et al. (2002). Novel O6-methylguanine-DNA methyltransferase SNPs: a frequency comparison of patients with familial melanoma and healthy individuals in Sweden. Hum Mutat, 20, 408-9.
7. Esteller M, Herman JG. (2004). Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene, 23, 1-8.
8. Etoh T, Kanai Y, Ushijima S, et al. (2004). Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol, 164, 689-99.
9. Gerson SL. (2004). MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer, 4, 296-307.
10. Hemminki K, Forsti A, Lorenzo BJ. (2005). Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events. J Carcinog, 4, 1-2.
11. Huang WY, Olshan AF, Schwartz SM, et al. (2005). Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev, 14, 1747-53.
12. Imai T, Oda H, Nakatsuru Y, Ishikawa T. (1995). A polymorphism at codon 160 of human O6-methylguanine DNA methyltransferase gene in young patients with adult type cancers and functional assay. Carcinogenesis, 16, 2441-5.
13. Inoue R, Abe M, Nakabeppu Y, et al. (2000). Characterization of human polymorphic DNA repair methyltransferase. Pharmacogenetics, 10, 59-66.
14. Ishibashi T, Nakabeppu Y, Sekiguchi M. (1994). Artificial control of nuclear translocation of DNA repairs methyltransferase. J Biol Chem, 269, 7645-50.
15. John SW, Weitzner G, Rozen R, Scriver CR. (1991). A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res, 19, 408.
16. Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S. (2001). DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer, 91, 205-12.
17. Kanai Y, Ushijima S, Ochiai A, et al. (1998). DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis. Cancer Lett, 122, 135-41.
18. Kanai Y, Ushijima S, Tsuda H, Sakamoto M, Hirohashi S. (2000). Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett, 148, 73-80.
19. Kanugula S, Goodtzova K, Edara S, Pegg AE. (1995). Alteration of arginine 128 to alanine abolishes the ability of human O6- alkylguanine-DNA alkyltransferase to repair methylated DNA but has no effect on its reaction with O6-benzylguanine. Biochemistry, 34, 7113-9.
20. Kaur TB, Travaline JM, Gaughan JP, et al. (2000). Role of polymorphisms in codons 143 and 160 of the O6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 339-42.
21. Kondo Y, Kanai Y, Sakamoto M, et al. (2000). Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology, 32, 970-9.
22. Leddin D, Hunt R, Champion M, et al. (2004). Canadian Association of Gastroenterology and Canadian Digestive Foundation. Guidelines on colon cancer screening. Can J Gastroenterol, 2, 93-9.
23. Ma S, Egyhazi S, Ueno T, et al. (2003). O6-methylguanine-DNAmethyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. Br J Cancer, 89, 1517-23.
24. Miao X, Yu C, Tan W, et al. (2003). A functional polymorphismin the matrix metalloproteinase-2 gene promoter (-1306C/ T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res, 63, 3987-90.
25. Mijal RS, Thomson NM, Fleischer NL, et al. (2004). The repair of the tobacco specific nitrosamine derived adduct O6-[4-Oxo-4-[3-pyridyl]butyl]guanine by O6-alkyl-guanine-DNA alkyltransferase variants. Chem Res Toxicol, 17, 424-34.
26. Okano M, Xie S, Li E. (1998). Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet, 19, 219-20.
27. Pettersson M, Bylund M, Alderborn A. (2003). Molecular haplotype determination using allele-specific PCR and pyrosequencing technology. Genomics, 82, 390-6.
28. Ritchey JD, Huang WY, Chokkalingam AP, et al. (2005). Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev, 14, 1703-9.
29. Ronaghi M. (2003). Pyrosequencing for SNP genotyping. Methods Mol Biol, 212, 189-95.
30. Saito Y, Kanai Y, Sakamoto M, et al. (2001). Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology, 33, 561-8.
31. Sauer S, Lechner D, Berlin K, et al. (2000). A novel procedure for efficient genotyping of single nucleotide polymorphisms. Nucleic Acids Res, 28, E13.
32. Shen L, KondoY, Rosner GL, et al. (2005). MGMT promoter methylation and field defect in sporadic sporadic colorectal cancer. J Natl Cancer Inst, 97, 1330-8.
33. Savas S, Kim DY, Ahmad MF, Shariff M, Ozcelik H. (2004). Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol Biomarkers Prev, 13, 801-7.
34. Tajinder BK, John M, Travaline JP, et al. (2000). Role of Polymorphisms in codons 143 and 160 of the O6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 339-42.
35. Tranah GJ, Bugni J, Giovannucci E, et al. (2006). O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the nurses' Health Study and Physicians' Health Study (United States). Cancer Causes Control, 17, 721-31.
36. Trasler JM, Trasler DG, Bestor TH, Li E, Ghibu F. (1996). DNA methyltransferase in normal and Dnmtn/Dnmtn mouse embryos. Dev Dyn, 206, 239-47.
37. Wu MH, Lohrbach KE, Olopade OI, et al. (1999). Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer. Clin Cancer Res, 5, 209-13.
38. Xu-Welliver M, Pegg AE. (2000). Point mutations at multiple sites including highly conserved amino acids maintain activity, but render O6-alkylguanine-DNA alkyltransferase insensitive to O6-benzylguanine. Biochem J, 347, 519-26.